Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia
<p>Abstract</p> <p>Background</p> <p>To assess the ejaculatory disorder caused by silodosin in the prostatic hyperplasia patients who carry out sexual actions (sexual intercourse, masturbation).</p> <p>Method</p> <p>The subjects of this study wer...
Main Authors: | Sakata Koichi, Morita Tatsuo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2490/12/29 |
Similar Items
-
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
by: Yoshida M, et al.
Published: (2011-06-01) -
Simultaneous estimation of silodosin and silodosin β-D-glucuronide in human plasma using LC-MS/MS for a pharmacokinetic study
by: Siva Sankara Rao Yadlapalli, et al.
Published: (2018-07-01) -
Comparative analysis of clinical effectiveness of α1-adrenoblockers doxazosin, tamsulosin and silodosin in males with chronic non-inflammatory prostatitis
by: A O Lobkarev, et al.
Published: (2018-12-01) -
Comparison of transurethral incision of the prostate and silodosin in patients having benign prostatic obstruction in terms of retrograde ejaculation
by: Basri Cakiroglu, et al.
Published: (2017-03-01) -
Evaluation of static and dynamic Pupillometry changes in men using Silodosin for benign prostatic hypertrophy
by: Umut Karaca, et al.
Published: (2021-03-01)